Cargando…
Molecular Mechanisms of MYCN Dysregulation in Cancers
MYCN, a member of MYC proto-oncogene family, encodes a basic helix-loop-helix transcription factor N-MYC. Abnormal expression of N-MYC is correlated with high-risk cancers and poor prognosis. Initially identified as an amplified oncogene in neuroblastoma in 1983, the oncogenic effect of N-MYC is exp...
Autores principales: | Liu, Ruochen, Shi, Pengfei, Wang, Zhongze, Yuan, Chaoyu, Cui, Hongjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886978/ https://www.ncbi.nlm.nih.gov/pubmed/33614505 http://dx.doi.org/10.3389/fonc.2020.625332 |
Ejemplares similares
-
Editorial: Molecular Mechanisms and Treatment of MYCN-Driven Tumors
por: Suenaga, Yusuke, et al.
Publicado: (2021) -
Molecular mechanisms of MYCN-dependent apoptosis and the MDM2–p53 pathway: an Achille’s heel to be exploited for the therapy of MYCN-amplified neuroblastoma
por: Petroni, Marialaura, et al.
Publicado: (2012) -
MYCN and the epigenome
por: He, Stanley, et al.
Publicado: (2013) -
Multiple mechanisms of MYCN dysregulation in Wilms tumour
por: Williams, Richard D., et al.
Publicado: (2015) -
Targeting MYCN in Pediatric and Adult Cancers
por: Liu, Zhihui, et al.
Publicado: (2021)